How Long Does Wegovy (Semaglutide) Take to Work?
Medically reviewed by Veronica Hackethal | MD, MSc, Harvard University | University of Oxford | Columbia Vagelos College of Physicians and Surgeons on September 6th, 2026.
Published on September 6th, 2026. Updated on September 6th, 2026.
Key takeaways
Appetite suppression often starts within weeks one to two, before any scale changes appear.
The 0.25 mg starting dose is a safety ramp, not a therapeutic weight loss dose.
Most patients do not reach the full 2.4 mg therapeutic dose until around week sixteen.
A benchmark of five percent weight loss by week sixteen to twenty signals meaningful drug response.
Rushing the dose schedule raises side effect risk without actually speeding up results.
How Long Does Semaglutide Actually Take to Work?
If you just started Wegovy and the scale is not budging yet, you are not doing anything wrong. Most people notice appetite suppression within the first one to two weeks, but meaningful weight loss typically becomes noticeable between weeks four and eight. The full effect builds over many months as your dose increases. That slower timeline is by design, not a sign the medication is failing you.
Semaglutide (the active ingredient in Wegovy) reaches a steady concentration in your bloodstream after about four to five weeks at any given dose. Clinical trial data from the STEP 1 trial showed an average 15% reduction in body weight by week 68 at the full 2.4 mg dose. Comparing your week-four results to that number is a setup for unnecessary frustration.
What Is the Dose Escalation Schedule, and Why Does It Matter?
Wegovy does not start at its full strength. The escalation schedule exists to give your body time to adjust and reduce side effects, particularly nausea. Here is how the steps work:
- Weeks 1 to 4: 0.25 mg weekly. This is a sub-therapeutic dose, meaning it is not expected to drive weight loss.
- Weeks 5 to 8: 0.5 mg weekly.
- Weeks 9 to 12: 1.0 mg weekly.
- Weeks 13 to 16: 1.7 mg weekly.
- Week 17 onward: 2.4 mg weekly, the full maintenance dose.
Most patients do not reach that final therapeutic dose until around week 16. Comparing early results to the trial outcomes, which were measured at week 68 at full dose, creates a deeply misleading picture of whether the drug is working.
A note that is worth saying plainly: taking a higher dose earlier than prescribed does not speed up weight loss. It meaningfully raises the risk of nausea, vomiting, and gastroparesis (a condition where the stomach empties too slowly), without any added benefit.
What Will You Notice First, and When?
The drug's effects tend to appear in a predictable order, and understanding that order helps you interpret what is happening.
Timeframe |
What Is Happening Biologically |
What You Typically Experience |
Worth Tracking? |
|---|---|---|---|
Weeks 1 to 2 |
GLP-1 receptors in the brain begin signaling fullness sooner |
Smaller appetite, feeling full faster at meals |
Yes, a strong early signal the drug is active |
Weeks 4 to 8 |
Dose increases, caloric intake drops more consistently |
First noticeable scale changes for many people |
Yes, but expect gradual movement |
Weeks 12 to 16 |
Approaching therapeutic dose range |
More consistent weight loss, reduced cravings |
Yes, this is the key response window |
Weeks 16 to 20 |
Full or near-full dose, steady-state concentration |
5% or more body weight loss expected in responders |
Critical benchmark for clinical decision-making |
Weeks 40 to 68 |
Sustained dose at 2.4 mg |
Maximum average weight loss seen in trials |
Long-term outcome window |
Nausea is the most common early side effect and typically peaks during each dose increase. It usually eases within one to two weeks at each new level. If nausea is severe or persistent, contact your prescribing clinician before adjusting anything on your own.
Do Some People Respond Faster or Slower?
Yes, and the variation is real and clinically recognized. Several factors influence your personal timeline:
- Baseline metabolic health: People with insulin resistance (when the body does not respond normally to insulin) may see a slower initial response.
- Gut motility: How quickly your digestive system moves food affects how the drug is absorbed and how side effects present.
- Type 2 diabetes: People using semaglutide (as Ozempic) for blood sugar control may notice blood glucose improvements within days, well before any weight changes appear.
- GLP-1 receptor genetics: A small subset of people have genetic differences that reduce their sensitivity to the medication. This is called true non-response, and it is a legitimate clinical issue, not a personal failure.
Clinicians typically identify non-responders by weeks 16 to 20 at a therapeutic dose of 1.7 mg or higher. If you have lost less than 5% of your body weight by that point, current guidelines support a conversation about whether to continue, adjust, or change the treatment plan.
What Does Not Speed Up Results?
A few things get marketed as ways to accelerate semaglutide's effects. They are worth addressing directly.
- Early dose escalation raises side effect risk without accelerating weight loss. The schedule exists for a clinical reason.
- Aggressive calorie restriction in the first month can actually make it harder to tell whether semaglutide alone is having its intended effect, and it is largely unnecessary given that the drug is already reducing appetite.
- Supplements marketed as "GLP-1 boosters" or "semaglutide enhancers" have no clinical trial evidence supporting their use. They are not worth the money, and some may interact with other medications.
How Do You Know If Semaglutide Is Working for You?
The clearest clinical benchmark is this: at least 5% body weight loss by weeks 16 to 20, at a dose of 1.0 mg or higher, suggests the medication is having a meaningful effect for you.
Before the scale moves much, tracking two other signals can help you stay grounded:
- Appetite changes: Are you eating smaller portions without effort? Feeling full sooner?
- Food noise reduction: "Food noise" is the term patients often use for constant preoccupation with eating. A reduction in this is a meaningful early sign.
If you reach week 20 at the 1.7 mg dose and have not hit the 5% threshold, that is not a failure. It is a clinical data point, and it is a reasonable time to reassess with your care team. Doctronic offers free AI consultations 24 hours a day, so you do not have to wait weeks for a clinic appointment to start that conversation. With 99.2% treatment plan alignment with board-certified physicians, an AI consultation can help you decide what questions to bring to your next visit.
Frequently Asked Questions
Most people who reach that milestone do so after several months at the full 2.4 mg dose. Clinical trial data showed an average 15% body weight reduction by week 68, so a 20-pound loss depends heavily on starting weight and individual response.
At week four you are likely still on the 0.25 mg starting dose, which is designed to minimize side effects, not drive weight loss. Meaningful changes on the scale typically begin around weeks four to eight as the dose increases.
Many people notice reduced appetite and earlier fullness at meals within the first one to two weeks, even at the lowest dose. This appetite signal often appears before any measurable change in body weight shows up.
Following the standard escalation schedule, 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg, each held for four weeks, most patients reach the full therapeutic dose around week sixteen.
A plateau after initial loss is common and does not always mean the drug has stopped working. If weight loss stalls significantly, guidelines support reassessing the treatment plan, including dose adjustments or adding behavioral strategies, with your clinician.
The Bottom Line
Semaglutide works on a predictable but gradual timeline tied directly to dose escalation. Appetite changes come first, scale changes follow, and the full therapeutic effect builds over months, not days. The five percent weight loss benchmark at weeks sixteen to twenty is the clinically accepted signal for whether the medication is working for you. Doctronic, with over 22 million AI consultations and 99.2% treatment plan alignment with board-certified physicians, can help you interpret your own timeline and decide when results are or are not adequate, without waiting weeks for a clinic appointment. Free AI consultations are available 24/7. This article is informational and is not a medical diagnosis. Confirm with a licensed clinician, especially for new, worsening, or high-risk symptoms.
Related articles
Explore treatment options
Chat Now